Elpiscience Files for Hong Kong IPO Focusing on Immunotherapy Pipeline
CompanyDeals

Elpiscience Files for Hong Kong IPO Focusing on Immunotherapy Pipeline

Medilink Therapeutics Collaborates with Wuhan Union Hospital on Clinical Trials
CompanyDeals

Medilink Therapeutics Collaborates with Wuhan Union Hospital on Clinical Trials

Duality Biologics Receives FDA IND Approval for EGFR/HER3 ADC AVZO-1418
CompanyDrug

Duality Biologics Receives FDA IND Approval for EGFR/HER3 ADC AVZO-1418

Zhejiang Huahai Gains MEDSAFE and HDEC Approval for HB0043 Phase I Trial
CompanyDrug

Zhejiang Huahai Gains MEDSAFE and HDEC Approval for HB0043 Phase I Trial

Bayer's Eylea 8 mg Close to EU Approval for Longer Treatment Intervals
CompanyDrug

Bayer’s Eylea 8 mg Close to EU Approval for Longer Treatment Intervals

Sichuan Kelun-Biotech Finalizes Licensing Deal for TSLP Monoclonal Antibody
CompanyDeals

Sichuan Kelun-Biotech Finalizes Licensing Deal for TSLP Monoclonal Antibody

Roche's Itovebi Recommended for EU Approval in PIK3CA-Mutated Breast Cancer
CompanyDrug

Roche’s Itovebi Recommended for EU Approval in PIK3CA-Mutated Breast Cancer

Jenscare Announces Positive 30-Day Results for LuX-Valve Plus in TRINITY Study
CompanyMedical Device

Jenscare Announces Positive 30-Day Results for LuX-Valve Plus in TRINITY Study

Roche Partners with Broad Clinical Labs to Advance SBX Sequencing Technology
CompanyDeals

Roche Partners with Broad Clinical Labs to Advance SBX Sequencing Technology

rand Pharma's GPN01768 Approved in Macau for Demodectic Blepharitis
CompanyDrug

Grand Pharma’s GPN01768 Approved in Macau for Demodectic Blepharitis

Medtronic's Prevail DCB Gains CE Mark for Expanded Coronary Disease Indications
CompanyMedical Device

Medtronic’s Prevail DCB Gains CE Mark for Expanded Coronary Disease Indications

Tonghua Dongbao to Sell Stake in Amoytop Biotech for USD 181 Million
CompanyDeals

Tonghua Dongbao to Sell Stake in Amoytop Biotech for USD 181 Million